Bullish & Foolish
Full TXMD fundamentals All 466 on the Survival Watch

TXMDTherapeuticsMD, Inc.

Is TherapeuticsMD struggling financially?

Yes, by its own account. TherapeuticsMD told the SEC on 12 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern. It generated cash over the last twelve months rather than burning it, so the doubt here is about something other than an empty bank account.

Going concern disclosed May 2026

30/100

Fragile

Sector
Biotech/Pharma
Market cap
$23.8M
Source filing
10-Q 12 May 2026
Balance sheet
30 Jun 2026

Cash runway

No net burn

This company generated cash over the last twelve months, so there is no burn rate to divide by. Going concern language in this position is usually about debt coming due or a covenant.

What it reported

Cash and short-term investments

$9.2M

What TherapeuticsMD told the SEC

…insufficient to satisfy our liquidity requirements. The potential impact of these factors in conjunction with the uncertainty of the capital markets raises substantial doubt about our ability to continue as a going concern for the next twelve months from the issuance of these financial statements. The accompanying condensed consolidated financial statements do not include any adjustments that might be…

TherapeuticsMD, Inc., Form 10-Q, filed 12 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

Other Biotech/Pharma companies that filed the doubt